Insulin‐like growth factor‐1 (IGF‐1) and pituitary adenylyl cyclase activating polypeptide (PACAP) are both potent neurotrophic and antiapoptotic factors, which exert their effects via …
V Dénes, N Czotter, M Lakk, G Berta, R Gabriel - Cell and tissue research, 2014 - Springer
Pituitary adenylate cyclase-activating polypeptide (PACAP), a member of the secretin/glucagon/vasoactive intestinal peptide family, exerts various effects on neuronal …
PM Germano, J Stalter, SV Le, M Wu, DJ Yamaguchi… - Peptides, 2001 - Elsevier
Fluor-PACAP, a fluorescent derivative of PACAP-27, has been confirmed to share a high affinity for PAC1 receptors transfected into NIH/3T3 cells and to have comparable …
As the brain develops, a homogeneous population of mitotically active progenitors generates the molecularly heterogeneous post-mitotic cells of the mature brain. The balance …
PK Campard, C Crochemore, F Rene… - DNA and cell …, 1997 - liebertpub.com
The molecular nature, transduction pathways, and neurotrophic functions of pituitary adenylate cyclase activating peptide (PACAP) receptors were studied in primary culture of …
Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide expressed in the trigeminal ganglia (TG). The TG conducts nociceptive signals in the head and may play roles …
Pituitary adenylate cyclase-activating polypeptide (PACAP) was first identified in hypothalamus, based on its ability to elevate cyclic AMP in the anterior pituitary. PACAP has …
E Ronaldson, DN Robertson, MS Johnson… - Regulatory peptides, 2002 - Elsevier
The PAC1, VPAC1 and VPAC2 receptors are members of the secretin (Group II) family of G protein-coupled receptors. All members of this family activate adenylate cyclase and several …